Cancer trials support unit (ctsu) IDIQ

Active Awarded Last action

Contract number
75N91022D00012
Awardee
Awarding agency
Task orders
1 $2,245 obligated

Award facts

Opportunity
Combined order value
$2,245 Current and potential, with all options
Last date to order 85% complete
IDV ceiling <1% used
$548,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Cancer Institute awarded an indefinite delivery/indefinite quantity multiple award contract to provide operational, administrative, regulatory, information technology, and logistical support services to support participation in multi-institutional cancer trials. Valued at up to $548 million over 10 years, the contract includes six task areas: project kick-off and transition activities, CTSU core support services and systems, awareness and training, site study set-up, protocol and scientific writing support, and electronic patient-reported outcomes. Task areas three, five and six are partially set aside for small businesses. PPD Development LP is the prime contractor.

The purpose is to provide centralized, integrated support for the National Cancer Institute and National Cancer Institute-funded networks' clinical trials. Services aim to streamline processes, reduce administrative burdens on clinical sites, and accelerate cancer research progress. This supports the National Cancer Institute's leadership of the National Cancer Program and management of research, training, and information activities nationwide. The original solicitation sought proposals for operational and logistical services under the six task areas to support participation in trials led by National Cancer Institute-supported organizations.

Task orders

Task order Ordering agency Obligated Awarded
Task order 1A project kick-off meeting 75N91022F00001 National Cancer Institute (NIH) $2,245

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N91022D00012?

75N91022D00012 was awarded to PPD Development LP by National Cancer Institute (National Institutes of Health) on August 1, 2022.

How much is contract 75N91022D00012 worth?

Orders under 75N91022D00012 have obligated $2,245. 75N91022D00012's own ceiling is $548,000,000.

How many orders have been placed under contract 75N91022D00012?

1 order has been placed under 75N91022D00012, the latest on August 1, 2022.

Who can order from contract 75N91022D00012?

75N91022D00012 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N91022D00012 part of a contract vehicle?

Yes. 75N91022D00012 is part of Cancer Trials Support Unit.

Was contract 75N91022D00012 competed?

The extent of competition for 75N91022D00012 was full and open competition. The government received 8 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV